Patient enrollment ongoing in phase II study of M-1095 in chronic plaque-type psoriasis Sep. 26, 2018
Antigen-expressing Listeria shows anticancer efficacy by remodeling the tumor microenvironment Sep. 26, 2018
Ribomic evaluating RBM-007 in phase I/II study in exudative age-related macular degeneration Sep. 26, 2018
Cerevance initiates first-in-human study of CVN-424 for the treatment of Parkinson's disease Sep. 26, 2018
RSS